93 A meta-analysis published in 2004 of findings from randomized placebo-controlled trials found 21.6% of subjects with tinnitus who were given ginkgo improved, while 18.4% of those given placebo improved, a difference that was not statistically significant
Herbert Atkinson in the UK were early adopters of prolotherapy for Joint Hypermobility Syndrome (the former name for what overlaps with hEDS), reporting that many patients achieved stability and pain relief with a regimen of injections to affected joints
Are seeking affordable wellness support
Researchers comparing klow vs glow peptide formulations choose KLOW when their protocol requires the melanocortin anti-inflammatory dimension that KPV adds to the foundational GHK-Cu, BPC-157, and TB-500 triple stack
Small molecules and hypoxia
The episodes of MCAS are idiopathic, as the activation mechanism is unknown